nodes	percent_of_prediction	percent_of_DWPC	metapath
Tranylcypromine—CYP2A6—prostate cancer	0.132	0.35	CbGaD
Tranylcypromine—CYP2E1—prostate cancer	0.0937	0.248	CbGaD
Tranylcypromine—CYP2C19—prostate cancer	0.0928	0.246	CbGaD
Tranylcypromine—CYP3A4—prostate cancer	0.059	0.156	CbGaD
Tranylcypromine—CYP2C19—Bicalutamide—prostate cancer	0.0237	0.0612	CbGbCtD
Tranylcypromine—CYP2C19—Nilutamide—prostate cancer	0.0237	0.0612	CbGbCtD
Tranylcypromine—CYP2E1—Estrone—prostate cancer	0.0227	0.0585	CbGbCtD
Tranylcypromine—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0218	0.0563	CbGbCtD
Tranylcypromine—CYP2C9—Bicalutamide—prostate cancer	0.0197	0.0509	CbGbCtD
Tranylcypromine—CYP2C9—Nilutamide—prostate cancer	0.0197	0.0509	CbGbCtD
Tranylcypromine—CYP2C19—Flutamide—prostate cancer	0.0196	0.0507	CbGbCtD
Tranylcypromine—CYP1A2—Flutamide—prostate cancer	0.0181	0.0468	CbGbCtD
Tranylcypromine—CYP2D6—Bicalutamide—prostate cancer	0.018	0.0465	CbGbCtD
Tranylcypromine—CYP2D6—Abiraterone—prostate cancer	0.0149	0.0386	CbGbCtD
Tranylcypromine—CYP2E1—Mitoxantrone—prostate cancer	0.0135	0.0348	CbGbCtD
Tranylcypromine—CYP1A2—Estrone—prostate cancer	0.0131	0.0338	CbGbCtD
Tranylcypromine—CYP2C9—Estrone—prostate cancer	0.0118	0.0305	CbGbCtD
Tranylcypromine—CYP3A4—Bicalutamide—prostate cancer	0.0115	0.0296	CbGbCtD
Tranylcypromine—CYP3A4—Estramustine—prostate cancer	0.0107	0.0275	CbGbCtD
Tranylcypromine—CYP3A4—Flutamide—prostate cancer	0.0095	0.0245	CbGbCtD
Tranylcypromine—CYP3A4—Abiraterone—prostate cancer	0.0095	0.0245	CbGbCtD
Tranylcypromine—CYP2C9—Capecitabine—prostate cancer	0.00895	0.0231	CbGbCtD
Tranylcypromine—CYP1A2—Conjugated Estrogens—prostate cancer	0.00857	0.0221	CbGbCtD
Tranylcypromine—CYP2E1—Etoposide—prostate cancer	0.0085	0.0219	CbGbCtD
Tranylcypromine—CYP2C19—Estradiol—prostate cancer	0.00816	0.0211	CbGbCtD
Tranylcypromine—CYP1A2—Estradiol—prostate cancer	0.00753	0.0194	CbGbCtD
Tranylcypromine—CYP3A4—Cabazitaxel—prostate cancer	0.00702	0.0181	CbGbCtD
Tranylcypromine—CYP2C19—Prednisone—prostate cancer	0.00701	0.0181	CbGbCtD
Tranylcypromine—CYP3A4—Estrone—prostate cancer	0.00687	0.0177	CbGbCtD
Tranylcypromine—CYP2C9—Estradiol—prostate cancer	0.00678	0.0175	CbGbCtD
Tranylcypromine—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00612	0.0158	CbGbCtD
Tranylcypromine—CYP1A2—Etoposide—prostate cancer	0.00491	0.0127	CbGbCtD
Tranylcypromine—CYP3A4—Conjugated Estrogens—prostate cancer	0.00449	0.0116	CbGbCtD
Tranylcypromine—CYP3A4—Mitoxantrone—prostate cancer	0.00408	0.0105	CbGbCtD
Tranylcypromine—CYP3A4—Estradiol—prostate cancer	0.00394	0.0102	CbGbCtD
Tranylcypromine—CYP3A4—Prednisone—prostate cancer	0.00339	0.00876	CbGbCtD
Tranylcypromine—CYP2D6—Doxorubicin—prostate cancer	0.00276	0.00713	CbGbCtD
Tranylcypromine—CYP3A4—Etoposide—prostate cancer	0.00257	0.00665	CbGbCtD
Tranylcypromine—CYP3A4—Docetaxel—prostate cancer	0.00236	0.00608	CbGbCtD
Tranylcypromine—CYP2C19—urine—prostate cancer	0.00227	0.0991	CbGeAlD
Tranylcypromine—CYP1A2—urine—prostate cancer	0.00185	0.081	CbGeAlD
Tranylcypromine—CYP2C9—urine—prostate cancer	0.00176	0.0769	CbGeAlD
Tranylcypromine—CYP3A4—Doxorubicin—prostate cancer	0.00176	0.00453	CbGbCtD
Tranylcypromine—CYP2E1—urine—prostate cancer	0.00167	0.0728	CbGeAlD
Tranylcypromine—CYP3A4—urine—prostate cancer	0.00134	0.0586	CbGeAlD
Tranylcypromine—CYP2D6—urine—prostate cancer	0.00132	0.0577	CbGeAlD
Tranylcypromine—CYP2A6—prostate gland—prostate cancer	0.00127	0.0553	CbGeAlD
Tranylcypromine—CYP2A6—seminal vesicle—prostate cancer	0.00107	0.0468	CbGeAlD
Tranylcypromine—MAOB—prostate gland—prostate cancer	0.000935	0.0408	CbGeAlD
Tranylcypromine—MAOA—prostate gland—prostate cancer	0.000797	0.0348	CbGeAlD
Tranylcypromine—MAOB—seminal vesicle—prostate cancer	0.000791	0.0345	CbGeAlD
Tranylcypromine—MAOA—seminal vesicle—prostate cancer	0.000674	0.0295	CbGeAlD
Tranylcypromine—MAOB—renal system—prostate cancer	0.000637	0.0278	CbGeAlD
Tranylcypromine—MAOB—urethra—prostate cancer	0.000626	0.0273	CbGeAlD
Tranylcypromine—CYP2E1—prostate gland—prostate cancer	0.000598	0.0261	CbGeAlD
Tranylcypromine—Phenelzine—CYP3A43—prostate cancer	0.000591	0.268	CrCbGaD
Tranylcypromine—MAOA—renal system—prostate cancer	0.000544	0.0237	CbGeAlD
Tranylcypromine—MAOA—urethra—prostate cancer	0.000534	0.0233	CbGeAlD
Tranylcypromine—CYP2E1—seminal vesicle—prostate cancer	0.000506	0.0221	CbGeAlD
Tranylcypromine—CYP1A2—renal system—prostate cancer	0.000453	0.0198	CbGeAlD
Tranylcypromine—MAOB—testis—prostate cancer	0.000412	0.018	CbGeAlD
Tranylcypromine—CYP2E1—renal system—prostate cancer	0.000408	0.0178	CbGeAlD
Tranylcypromine—CYP2E1—urethra—prostate cancer	0.000401	0.0175	CbGeAlD
Tranylcypromine—MAOA—testis—prostate cancer	0.000351	0.0153	CbGeAlD
Tranylcypromine—CYP3A4—renal system—prostate cancer	0.000328	0.0143	CbGeAlD
Tranylcypromine—CYP2D6—renal system—prostate cancer	0.000323	0.0141	CbGeAlD
Tranylcypromine—MAOB—lymph node—prostate cancer	0.000298	0.013	CbGeAlD
Tranylcypromine—CYP2E1—testis—prostate cancer	0.000264	0.0115	CbGeAlD
Tranylcypromine—MAOA—lymph node—prostate cancer	0.000255	0.0111	CbGeAlD
Tranylcypromine—Amphetamine—SLC22A3—prostate cancer	0.000241	0.11	CrCbGaD
Tranylcypromine—CYP2D6—testis—prostate cancer	0.000209	0.00912	CbGeAlD
Tranylcypromine—Phensuximide—CYP2C19—prostate cancer	0.000198	0.0897	CrCbGaD
Tranylcypromine—Phenylpropanolamine—ADRB2—prostate cancer	0.000161	0.0732	CrCbGaD
Tranylcypromine—Phenelzine—CYP3A5—prostate cancer	0.000148	0.0672	CrCbGaD
Tranylcypromine—Ethotoin—CYP2C19—prostate cancer	0.000146	0.0665	CrCbGaD
Tranylcypromine—Amphetamine—CYP2A6—prostate cancer	0.000135	0.0614	CrCbGaD
Tranylcypromine—Benzyl alcohol—CYP2E1—prostate cancer	0.00012	0.0547	CrCbGaD
Tranylcypromine—Benzyl alcohol—CYP1A1—prostate cancer	0.000119	0.0539	CrCbGaD
Tranylcypromine—Phenelzine—CYP2E1—prostate cancer	0.000102	0.0462	CrCbGaD
Tranylcypromine—Phenelzine—CYP2C19—prostate cancer	0.000101	0.0458	CrCbGaD
Tranylcypromine—Alopecia—Capecitabine—prostate cancer	8.17e-05	0.000744	CcSEcCtD
Tranylcypromine—Ataxia—Doxorubicin—prostate cancer	8.1e-05	0.000737	CcSEcCtD
Tranylcypromine—Feeling abnormal—Mitoxantrone—prostate cancer	8.09e-05	0.000736	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Mitoxantrone—prostate cancer	8.03e-05	0.000731	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Etoposide—prostate cancer	7.99e-05	0.000728	CcSEcCtD
Tranylcypromine—Muscle spasms—Docetaxel—prostate cancer	7.99e-05	0.000728	CcSEcCtD
Tranylcypromine—Tachycardia—Etoposide—prostate cancer	7.97e-05	0.000725	CcSEcCtD
Tranylcypromine—Nausea—Goserelin—prostate cancer	7.89e-05	0.000718	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Etoposide—prostate cancer	7.89e-05	0.000718	CcSEcCtD
Tranylcypromine—Nausea—Conjugated Estrogens—prostate cancer	7.82e-05	0.000712	CcSEcCtD
Tranylcypromine—Urticaria—Mitoxantrone—prostate cancer	7.8e-05	0.00071	CcSEcCtD
Tranylcypromine—Anorexia—Etoposide—prostate cancer	7.78e-05	0.000708	CcSEcCtD
Tranylcypromine—Abdominal pain—Mitoxantrone—prostate cancer	7.76e-05	0.000706	CcSEcCtD
Tranylcypromine—Body temperature increased—Mitoxantrone—prostate cancer	7.76e-05	0.000706	CcSEcCtD
Tranylcypromine—Muscle spasms—Capecitabine—prostate cancer	7.74e-05	0.000704	CcSEcCtD
Tranylcypromine—Anaemia—Docetaxel—prostate cancer	7.68e-05	0.000699	CcSEcCtD
Tranylcypromine—Flushing—Prednisone—prostate cancer	7.64e-05	0.000696	CcSEcCtD
Tranylcypromine—Hypotension—Etoposide—prostate cancer	7.63e-05	0.000694	CcSEcCtD
Tranylcypromine—Vision blurred—Capecitabine—prostate cancer	7.59e-05	0.00069	CcSEcCtD
Tranylcypromine—Benzyl alcohol—CYP3A4—prostate cancer	7.58e-05	0.0344	CrCbGaD
Tranylcypromine—Asthenia—Estradiol—prostate cancer	7.56e-05	0.000688	CcSEcCtD
Tranylcypromine—Tremor—Capecitabine—prostate cancer	7.54e-05	0.000686	CcSEcCtD
Tranylcypromine—Syncope—Docetaxel—prostate cancer	7.46e-05	0.000679	CcSEcCtD
Tranylcypromine—Leukopenia—Docetaxel—prostate cancer	7.44e-05	0.000677	CcSEcCtD
Tranylcypromine—Anaemia—Capecitabine—prostate cancer	7.44e-05	0.000677	CcSEcCtD
Tranylcypromine—Pollakiuria—Epirubicin—prostate cancer	7.43e-05	0.000677	CcSEcCtD
Tranylcypromine—Palpitations—Docetaxel—prostate cancer	7.35e-05	0.000669	CcSEcCtD
Tranylcypromine—Paraesthesia—Etoposide—prostate cancer	7.33e-05	0.000667	CcSEcCtD
Tranylcypromine—Loss of consciousness—Docetaxel—prostate cancer	7.31e-05	0.000665	CcSEcCtD
Tranylcypromine—Alopecia—Prednisone—prostate cancer	7.28e-05	0.000662	CcSEcCtD
Tranylcypromine—Somnolence—Etoposide—prostate cancer	7.26e-05	0.000661	CcSEcCtD
Tranylcypromine—Syncope—Capecitabine—prostate cancer	7.22e-05	0.000657	CcSEcCtD
Tranylcypromine—Diarrhoea—Estradiol—prostate cancer	7.21e-05	0.000656	CcSEcCtD
Tranylcypromine—Leukopenia—Capecitabine—prostate cancer	7.2e-05	0.000656	CcSEcCtD
Tranylcypromine—Hypertension—Docetaxel—prostate cancer	7.18e-05	0.000653	CcSEcCtD
Tranylcypromine—Drowsiness—Epirubicin—prostate cancer	7.18e-05	0.000653	CcSEcCtD
Tranylcypromine—Palpitations—Capecitabine—prostate cancer	7.11e-05	0.000647	CcSEcCtD
Tranylcypromine—Decreased appetite—Etoposide—prostate cancer	7.1e-05	0.000646	CcSEcCtD
Tranylcypromine—Loss of consciousness—Capecitabine—prostate cancer	7.07e-05	0.000644	CcSEcCtD
Tranylcypromine—Asthenia—Mitoxantrone—prostate cancer	7.04e-05	0.000641	CcSEcCtD
Tranylcypromine—Pain—Etoposide—prostate cancer	6.98e-05	0.000635	CcSEcCtD
Tranylcypromine—Constipation—Etoposide—prostate cancer	6.98e-05	0.000635	CcSEcCtD
Tranylcypromine—Dizziness—Estradiol—prostate cancer	6.97e-05	0.000634	CcSEcCtD
Tranylcypromine—Hypertension—Capecitabine—prostate cancer	6.95e-05	0.000633	CcSEcCtD
Tranylcypromine—Dry mouth—Docetaxel—prostate cancer	6.92e-05	0.00063	CcSEcCtD
Tranylcypromine—Sweating—Epirubicin—prostate cancer	6.88e-05	0.000626	CcSEcCtD
Tranylcypromine—Pollakiuria—Doxorubicin—prostate cancer	6.88e-05	0.000626	CcSEcCtD
Tranylcypromine—Confusional state—Docetaxel—prostate cancer	6.84e-05	0.000623	CcSEcCtD
Tranylcypromine—Anxiety—Capecitabine—prostate cancer	6.83e-05	0.000622	CcSEcCtD
Tranylcypromine—Oedema—Docetaxel—prostate cancer	6.78e-05	0.000618	CcSEcCtD
Tranylcypromine—Vision blurred—Prednisone—prostate cancer	6.76e-05	0.000615	CcSEcCtD
Tranylcypromine—Feeling abnormal—Etoposide—prostate cancer	6.73e-05	0.000612	CcSEcCtD
Tranylcypromine—Diarrhoea—Mitoxantrone—prostate cancer	6.72e-05	0.000611	CcSEcCtD
Tranylcypromine—Dry mouth—Capecitabine—prostate cancer	6.7e-05	0.00061	CcSEcCtD
Tranylcypromine—Vomiting—Estradiol—prostate cancer	6.7e-05	0.00061	CcSEcCtD
Tranylcypromine—Agranulocytosis—Epirubicin—prostate cancer	6.7e-05	0.00061	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Etoposide—prostate cancer	6.68e-05	0.000608	CcSEcCtD
Tranylcypromine—Shock—Docetaxel—prostate cancer	6.68e-05	0.000608	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Docetaxel—prostate cancer	6.64e-05	0.000605	CcSEcCtD
Tranylcypromine—Rash—Estradiol—prostate cancer	6.64e-05	0.000605	CcSEcCtD
Tranylcypromine—Drowsiness—Doxorubicin—prostate cancer	6.64e-05	0.000604	CcSEcCtD
Tranylcypromine—Dermatitis—Estradiol—prostate cancer	6.64e-05	0.000604	CcSEcCtD
Tranylcypromine—Anaemia—Prednisone—prostate cancer	6.63e-05	0.000603	CcSEcCtD
Tranylcypromine—Confusional state—Capecitabine—prostate cancer	6.62e-05	0.000603	CcSEcCtD
Tranylcypromine—Tachycardia—Docetaxel—prostate cancer	6.62e-05	0.000603	CcSEcCtD
Tranylcypromine—Headache—Estradiol—prostate cancer	6.6e-05	0.000601	CcSEcCtD
Tranylcypromine—Agitation—Prednisone—prostate cancer	6.59e-05	0.0006	CcSEcCtD
Tranylcypromine—Oedema—Capecitabine—prostate cancer	6.57e-05	0.000598	CcSEcCtD
Tranylcypromine—Bradycardia—Epirubicin—prostate cancer	6.56e-05	0.000597	CcSEcCtD
Tranylcypromine—Urticaria—Etoposide—prostate cancer	6.49e-05	0.00059	CcSEcCtD
Tranylcypromine—Haemoglobin—Epirubicin—prostate cancer	6.47e-05	0.000589	CcSEcCtD
Tranylcypromine—Anorexia—Docetaxel—prostate cancer	6.47e-05	0.000589	CcSEcCtD
Tranylcypromine—Shock—Capecitabine—prostate cancer	6.46e-05	0.000588	CcSEcCtD
Tranylcypromine—Abdominal pain—Etoposide—prostate cancer	6.45e-05	0.000587	CcSEcCtD
Tranylcypromine—Body temperature increased—Etoposide—prostate cancer	6.45e-05	0.000587	CcSEcCtD
Tranylcypromine—Haemorrhage—Epirubicin—prostate cancer	6.44e-05	0.000586	CcSEcCtD
Tranylcypromine—Hepatitis—Epirubicin—prostate cancer	6.44e-05	0.000586	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Capecitabine—prostate cancer	6.43e-05	0.000585	CcSEcCtD
Tranylcypromine—Syncope—Prednisone—prostate cancer	6.43e-05	0.000585	CcSEcCtD
Tranylcypromine—Tachycardia—Capecitabine—prostate cancer	6.41e-05	0.000584	CcSEcCtD
Tranylcypromine—Hypoaesthesia—Epirubicin—prostate cancer	6.41e-05	0.000583	CcSEcCtD
Tranylcypromine—Phenelzine—CYP3A4—prostate cancer	6.41e-05	0.0291	CrCbGaD
Tranylcypromine—Sweating—Doxorubicin—prostate cancer	6.37e-05	0.000579	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Capecitabine—prostate cancer	6.35e-05	0.000578	CcSEcCtD
Tranylcypromine—Hypotension—Docetaxel—prostate cancer	6.34e-05	0.000577	CcSEcCtD
Tranylcypromine—Loss of consciousness—Prednisone—prostate cancer	6.3e-05	0.000574	CcSEcCtD
Tranylcypromine—Anorexia—Capecitabine—prostate cancer	6.26e-05	0.00057	CcSEcCtD
Tranylcypromine—Nausea—Estradiol—prostate cancer	6.26e-05	0.00057	CcSEcCtD
Tranylcypromine—Vomiting—Mitoxantrone—prostate cancer	6.24e-05	0.000568	CcSEcCtD
Tranylcypromine—Agranulocytosis—Doxorubicin—prostate cancer	6.2e-05	0.000564	CcSEcCtD
Tranylcypromine—Hypertension—Prednisone—prostate cancer	6.19e-05	0.000563	CcSEcCtD
Tranylcypromine—Rash—Mitoxantrone—prostate cancer	6.19e-05	0.000563	CcSEcCtD
Tranylcypromine—Dermatitis—Mitoxantrone—prostate cancer	6.18e-05	0.000563	CcSEcCtD
Tranylcypromine—Headache—Mitoxantrone—prostate cancer	6.15e-05	0.00056	CcSEcCtD
Tranylcypromine—Hypotension—Capecitabine—prostate cancer	6.14e-05	0.000559	CcSEcCtD
Tranylcypromine—Insomnia—Docetaxel—prostate cancer	6.14e-05	0.000559	CcSEcCtD
Tranylcypromine—Paraesthesia—Docetaxel—prostate cancer	6.09e-05	0.000555	CcSEcCtD
Tranylcypromine—Anxiety—Prednisone—prostate cancer	6.08e-05	0.000554	CcSEcCtD
Tranylcypromine—Bradycardia—Doxorubicin—prostate cancer	6.07e-05	0.000552	CcSEcCtD
Tranylcypromine—Somnolence—Docetaxel—prostate cancer	6.03e-05	0.000549	CcSEcCtD
Tranylcypromine—Tinnitus—Epirubicin—prostate cancer	6.01e-05	0.000547	CcSEcCtD
Tranylcypromine—Haemoglobin—Doxorubicin—prostate cancer	5.99e-05	0.000545	CcSEcCtD
Tranylcypromine—Flushing—Epirubicin—prostate cancer	5.98e-05	0.000544	CcSEcCtD
Tranylcypromine—Haemorrhage—Doxorubicin—prostate cancer	5.96e-05	0.000543	CcSEcCtD
Tranylcypromine—Hepatitis—Doxorubicin—prostate cancer	5.96e-05	0.000543	CcSEcCtD
Tranylcypromine—Insomnia—Capecitabine—prostate cancer	5.94e-05	0.000541	CcSEcCtD
Tranylcypromine—Hypoaesthesia—Doxorubicin—prostate cancer	5.93e-05	0.00054	CcSEcCtD
Tranylcypromine—Paraesthesia—Capecitabine—prostate cancer	5.9e-05	0.000537	CcSEcCtD
Tranylcypromine—Decreased appetite—Docetaxel—prostate cancer	5.9e-05	0.000537	CcSEcCtD
Tranylcypromine—Asthenia—Etoposide—prostate cancer	5.86e-05	0.000533	CcSEcCtD
Tranylcypromine—Oedema—Prednisone—prostate cancer	5.85e-05	0.000533	CcSEcCtD
Tranylcypromine—Nausea—Mitoxantrone—prostate cancer	5.83e-05	0.000531	CcSEcCtD
Tranylcypromine—Constipation—Docetaxel—prostate cancer	5.8e-05	0.000528	CcSEcCtD
Tranylcypromine—Pain—Docetaxel—prostate cancer	5.8e-05	0.000528	CcSEcCtD
Tranylcypromine—Chills—Epirubicin—prostate cancer	5.78e-05	0.000526	CcSEcCtD
Tranylcypromine—Shock—Prednisone—prostate cancer	5.76e-05	0.000524	CcSEcCtD
Tranylcypromine—Tachycardia—Prednisone—prostate cancer	5.71e-05	0.00052	CcSEcCtD
Tranylcypromine—Decreased appetite—Capecitabine—prostate cancer	5.71e-05	0.00052	CcSEcCtD
Tranylcypromine—Alopecia—Epirubicin—prostate cancer	5.69e-05	0.000518	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Prednisone—prostate cancer	5.66e-05	0.000515	CcSEcCtD
Tranylcypromine—Pain—Capecitabine—prostate cancer	5.62e-05	0.000511	CcSEcCtD
Tranylcypromine—Constipation—Capecitabine—prostate cancer	5.62e-05	0.000511	CcSEcCtD
Tranylcypromine—Feeling abnormal—Docetaxel—prostate cancer	5.59e-05	0.000509	CcSEcCtD
Tranylcypromine—Diarrhoea—Etoposide—prostate cancer	5.59e-05	0.000508	CcSEcCtD
Tranylcypromine—Anorexia—Prednisone—prostate cancer	5.58e-05	0.000508	CcSEcCtD
Tranylcypromine—Tinnitus—Doxorubicin—prostate cancer	5.56e-05	0.000506	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Docetaxel—prostate cancer	5.55e-05	0.000505	CcSEcCtD
Tranylcypromine—Flushing—Doxorubicin—prostate cancer	5.53e-05	0.000504	CcSEcCtD
Tranylcypromine—Feeling abnormal—Capecitabine—prostate cancer	5.41e-05	0.000493	CcSEcCtD
Tranylcypromine—Dizziness—Etoposide—prostate cancer	5.4e-05	0.000491	CcSEcCtD
Tranylcypromine—Muscle spasms—Epirubicin—prostate cancer	5.39e-05	0.000491	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Capecitabine—prostate cancer	5.37e-05	0.000489	CcSEcCtD
Tranylcypromine—Abdominal pain—Docetaxel—prostate cancer	5.36e-05	0.000488	CcSEcCtD
Tranylcypromine—Body temperature increased—Docetaxel—prostate cancer	5.36e-05	0.000488	CcSEcCtD
Tranylcypromine—Chills—Doxorubicin—prostate cancer	5.35e-05	0.000487	CcSEcCtD
Tranylcypromine—Insomnia—Prednisone—prostate cancer	5.29e-05	0.000482	CcSEcCtD
Tranylcypromine—Vision blurred—Epirubicin—prostate cancer	5.28e-05	0.000481	CcSEcCtD
Tranylcypromine—Alopecia—Doxorubicin—prostate cancer	5.27e-05	0.000479	CcSEcCtD
Tranylcypromine—Paraesthesia—Prednisone—prostate cancer	5.25e-05	0.000478	CcSEcCtD
Tranylcypromine—Urticaria—Capecitabine—prostate cancer	5.22e-05	0.000475	CcSEcCtD
Tranylcypromine—Body temperature increased—Capecitabine—prostate cancer	5.19e-05	0.000473	CcSEcCtD
Tranylcypromine—Abdominal pain—Capecitabine—prostate cancer	5.19e-05	0.000473	CcSEcCtD
Tranylcypromine—Vomiting—Etoposide—prostate cancer	5.19e-05	0.000473	CcSEcCtD
Tranylcypromine—Anaemia—Epirubicin—prostate cancer	5.18e-05	0.000472	CcSEcCtD
Tranylcypromine—Agitation—Epirubicin—prostate cancer	5.15e-05	0.000469	CcSEcCtD
Tranylcypromine—Rash—Etoposide—prostate cancer	5.15e-05	0.000469	CcSEcCtD
Tranylcypromine—Dermatitis—Etoposide—prostate cancer	5.14e-05	0.000468	CcSEcCtD
Tranylcypromine—Headache—Etoposide—prostate cancer	5.11e-05	0.000466	CcSEcCtD
Tranylcypromine—Decreased appetite—Prednisone—prostate cancer	5.09e-05	0.000463	CcSEcCtD
Tranylcypromine—Syncope—Epirubicin—prostate cancer	5.03e-05	0.000458	CcSEcCtD
Tranylcypromine—Leukopenia—Epirubicin—prostate cancer	5.02e-05	0.000457	CcSEcCtD
Tranylcypromine—Constipation—Prednisone—prostate cancer	5e-05	0.000455	CcSEcCtD
Tranylcypromine—Muscle spasms—Doxorubicin—prostate cancer	4.99e-05	0.000454	CcSEcCtD
Tranylcypromine—Palpitations—Epirubicin—prostate cancer	4.96e-05	0.000451	CcSEcCtD
Tranylcypromine—Loss of consciousness—Epirubicin—prostate cancer	4.93e-05	0.000449	CcSEcCtD
Tranylcypromine—Vision blurred—Doxorubicin—prostate cancer	4.89e-05	0.000445	CcSEcCtD
Tranylcypromine—Asthenia—Docetaxel—prostate cancer	4.87e-05	0.000443	CcSEcCtD
Tranylcypromine—Nausea—Etoposide—prostate cancer	4.85e-05	0.000441	CcSEcCtD
Tranylcypromine—Hypertension—Epirubicin—prostate cancer	4.84e-05	0.000441	CcSEcCtD
Tranylcypromine—Feeling abnormal—Prednisone—prostate cancer	4.82e-05	0.000439	CcSEcCtD
Tranylcypromine—Anaemia—Doxorubicin—prostate cancer	4.8e-05	0.000437	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Prednisone—prostate cancer	4.78e-05	0.000436	CcSEcCtD
Tranylcypromine—Agitation—Doxorubicin—prostate cancer	4.77e-05	0.000434	CcSEcCtD
Tranylcypromine—Anxiety—Epirubicin—prostate cancer	4.76e-05	0.000433	CcSEcCtD
Tranylcypromine—Asthenia—Capecitabine—prostate cancer	4.71e-05	0.000429	CcSEcCtD
Tranylcypromine—Dry mouth—Epirubicin—prostate cancer	4.67e-05	0.000425	CcSEcCtD
Tranylcypromine—Syncope—Doxorubicin—prostate cancer	4.65e-05	0.000424	CcSEcCtD
Tranylcypromine—Urticaria—Prednisone—prostate cancer	4.65e-05	0.000423	CcSEcCtD
Tranylcypromine—Leukopenia—Doxorubicin—prostate cancer	4.64e-05	0.000423	CcSEcCtD
Tranylcypromine—Diarrhoea—Docetaxel—prostate cancer	4.64e-05	0.000423	CcSEcCtD
Tranylcypromine—Abdominal pain—Prednisone—prostate cancer	4.63e-05	0.000421	CcSEcCtD
Tranylcypromine—Body temperature increased—Prednisone—prostate cancer	4.63e-05	0.000421	CcSEcCtD
Tranylcypromine—Confusional state—Epirubicin—prostate cancer	4.61e-05	0.00042	CcSEcCtD
Tranylcypromine—Palpitations—Doxorubicin—prostate cancer	4.59e-05	0.000417	CcSEcCtD
Tranylcypromine—Oedema—Epirubicin—prostate cancer	4.58e-05	0.000417	CcSEcCtD
Tranylcypromine—Loss of consciousness—Doxorubicin—prostate cancer	4.56e-05	0.000415	CcSEcCtD
Tranylcypromine—Shock—Epirubicin—prostate cancer	4.5e-05	0.00041	CcSEcCtD
Tranylcypromine—Diarrhoea—Capecitabine—prostate cancer	4.49e-05	0.000409	CcSEcCtD
Tranylcypromine—Dizziness—Docetaxel—prostate cancer	4.49e-05	0.000408	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Epirubicin—prostate cancer	4.48e-05	0.000408	CcSEcCtD
Tranylcypromine—Hypertension—Doxorubicin—prostate cancer	4.48e-05	0.000408	CcSEcCtD
Tranylcypromine—Tachycardia—Epirubicin—prostate cancer	4.47e-05	0.000407	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Epirubicin—prostate cancer	4.42e-05	0.000403	CcSEcCtD
Tranylcypromine—Anxiety—Doxorubicin—prostate cancer	4.4e-05	0.000401	CcSEcCtD
Tranylcypromine—Anorexia—Epirubicin—prostate cancer	4.36e-05	0.000397	CcSEcCtD
Tranylcypromine—Dizziness—Capecitabine—prostate cancer	4.34e-05	0.000395	CcSEcCtD
Tranylcypromine—Dry mouth—Doxorubicin—prostate cancer	4.32e-05	0.000393	CcSEcCtD
Tranylcypromine—Vomiting—Docetaxel—prostate cancer	4.31e-05	0.000393	CcSEcCtD
Tranylcypromine—Rash—Docetaxel—prostate cancer	4.28e-05	0.000389	CcSEcCtD
Tranylcypromine—Hypotension—Epirubicin—prostate cancer	4.28e-05	0.000389	CcSEcCtD
Tranylcypromine—Dermatitis—Docetaxel—prostate cancer	4.27e-05	0.000389	CcSEcCtD
Tranylcypromine—Confusional state—Doxorubicin—prostate cancer	4.27e-05	0.000389	CcSEcCtD
Tranylcypromine—Headache—Docetaxel—prostate cancer	4.25e-05	0.000387	CcSEcCtD
Tranylcypromine—Oedema—Doxorubicin—prostate cancer	4.23e-05	0.000385	CcSEcCtD
Tranylcypromine—Asthenia—Prednisone—prostate cancer	4.2e-05	0.000382	CcSEcCtD
Tranylcypromine—Vomiting—Capecitabine—prostate cancer	4.18e-05	0.00038	CcSEcCtD
Tranylcypromine—Shock—Doxorubicin—prostate cancer	4.17e-05	0.000379	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Doxorubicin—prostate cancer	4.15e-05	0.000377	CcSEcCtD
Tranylcypromine—Rash—Capecitabine—prostate cancer	4.14e-05	0.000377	CcSEcCtD
Tranylcypromine—Insomnia—Epirubicin—prostate cancer	4.14e-05	0.000377	CcSEcCtD
Tranylcypromine—Dermatitis—Capecitabine—prostate cancer	4.14e-05	0.000377	CcSEcCtD
Tranylcypromine—Tachycardia—Doxorubicin—prostate cancer	4.13e-05	0.000376	CcSEcCtD
Tranylcypromine—Headache—Capecitabine—prostate cancer	4.12e-05	0.000375	CcSEcCtD
Tranylcypromine—Paraesthesia—Epirubicin—prostate cancer	4.11e-05	0.000374	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Doxorubicin—prostate cancer	4.09e-05	0.000373	CcSEcCtD
Tranylcypromine—Somnolence—Epirubicin—prostate cancer	4.07e-05	0.00037	CcSEcCtD
Tranylcypromine—Anorexia—Doxorubicin—prostate cancer	4.04e-05	0.000367	CcSEcCtD
Tranylcypromine—Nausea—Docetaxel—prostate cancer	4.03e-05	0.000367	CcSEcCtD
Tranylcypromine—Diarrhoea—Prednisone—prostate cancer	4e-05	0.000364	CcSEcCtD
Tranylcypromine—Decreased appetite—Epirubicin—prostate cancer	3.98e-05	0.000362	CcSEcCtD
Tranylcypromine—Hypotension—Doxorubicin—prostate cancer	3.96e-05	0.00036	CcSEcCtD
Tranylcypromine—Pain—Epirubicin—prostate cancer	3.91e-05	0.000356	CcSEcCtD
Tranylcypromine—Constipation—Epirubicin—prostate cancer	3.91e-05	0.000356	CcSEcCtD
Tranylcypromine—Nausea—Capecitabine—prostate cancer	3.9e-05	0.000355	CcSEcCtD
Tranylcypromine—Dizziness—Prednisone—prostate cancer	3.87e-05	0.000352	CcSEcCtD
Tranylcypromine—Insomnia—Doxorubicin—prostate cancer	3.83e-05	0.000349	CcSEcCtD
Tranylcypromine—Paraesthesia—Doxorubicin—prostate cancer	3.8e-05	0.000346	CcSEcCtD
Tranylcypromine—Feeling abnormal—Epirubicin—prostate cancer	3.77e-05	0.000343	CcSEcCtD
Tranylcypromine—Somnolence—Doxorubicin—prostate cancer	3.76e-05	0.000343	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Epirubicin—prostate cancer	3.74e-05	0.000341	CcSEcCtD
Tranylcypromine—Vomiting—Prednisone—prostate cancer	3.72e-05	0.000339	CcSEcCtD
Tranylcypromine—Rash—Prednisone—prostate cancer	3.69e-05	0.000336	CcSEcCtD
Tranylcypromine—Dermatitis—Prednisone—prostate cancer	3.69e-05	0.000336	CcSEcCtD
Tranylcypromine—Decreased appetite—Doxorubicin—prostate cancer	3.68e-05	0.000335	CcSEcCtD
Tranylcypromine—Headache—Prednisone—prostate cancer	3.67e-05	0.000334	CcSEcCtD
Tranylcypromine—Urticaria—Epirubicin—prostate cancer	3.64e-05	0.000331	CcSEcCtD
Tranylcypromine—Constipation—Doxorubicin—prostate cancer	3.62e-05	0.00033	CcSEcCtD
Tranylcypromine—Pain—Doxorubicin—prostate cancer	3.62e-05	0.00033	CcSEcCtD
Tranylcypromine—Abdominal pain—Epirubicin—prostate cancer	3.62e-05	0.000329	CcSEcCtD
Tranylcypromine—Body temperature increased—Epirubicin—prostate cancer	3.62e-05	0.000329	CcSEcCtD
Tranylcypromine—Feeling abnormal—Doxorubicin—prostate cancer	3.49e-05	0.000318	CcSEcCtD
Tranylcypromine—Nausea—Prednisone—prostate cancer	3.48e-05	0.000316	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Doxorubicin—prostate cancer	3.46e-05	0.000315	CcSEcCtD
Tranylcypromine—Urticaria—Doxorubicin—prostate cancer	3.36e-05	0.000306	CcSEcCtD
Tranylcypromine—Abdominal pain—Doxorubicin—prostate cancer	3.35e-05	0.000305	CcSEcCtD
Tranylcypromine—Body temperature increased—Doxorubicin—prostate cancer	3.35e-05	0.000305	CcSEcCtD
Tranylcypromine—Asthenia—Epirubicin—prostate cancer	3.28e-05	0.000299	CcSEcCtD
Tranylcypromine—Diarrhoea—Epirubicin—prostate cancer	3.13e-05	0.000285	CcSEcCtD
Tranylcypromine—Asthenia—Doxorubicin—prostate cancer	3.04e-05	0.000277	CcSEcCtD
Tranylcypromine—Dizziness—Epirubicin—prostate cancer	3.03e-05	0.000275	CcSEcCtD
Tranylcypromine—Vomiting—Epirubicin—prostate cancer	2.91e-05	0.000265	CcSEcCtD
Tranylcypromine—Diarrhoea—Doxorubicin—prostate cancer	2.9e-05	0.000264	CcSEcCtD
Tranylcypromine—Rash—Epirubicin—prostate cancer	2.89e-05	0.000263	CcSEcCtD
Tranylcypromine—Dermatitis—Epirubicin—prostate cancer	2.88e-05	0.000262	CcSEcCtD
Tranylcypromine—Headache—Epirubicin—prostate cancer	2.87e-05	0.000261	CcSEcCtD
Tranylcypromine—Dizziness—Doxorubicin—prostate cancer	2.8e-05	0.000255	CcSEcCtD
Tranylcypromine—Nausea—Epirubicin—prostate cancer	2.72e-05	0.000247	CcSEcCtD
Tranylcypromine—Vomiting—Doxorubicin—prostate cancer	2.69e-05	0.000245	CcSEcCtD
Tranylcypromine—Rash—Doxorubicin—prostate cancer	2.67e-05	0.000243	CcSEcCtD
Tranylcypromine—Dermatitis—Doxorubicin—prostate cancer	2.67e-05	0.000243	CcSEcCtD
Tranylcypromine—Headache—Doxorubicin—prostate cancer	2.65e-05	0.000241	CcSEcCtD
Tranylcypromine—Nausea—Doxorubicin—prostate cancer	2.52e-05	0.000229	CcSEcCtD
Tranylcypromine—CYP3A4—Metabolism—TBXAS1—prostate cancer	2.79e-06	2.79e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—NQO1—prostate cancer	2.78e-06	2.78e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—NCOA2—prostate cancer	2.78e-06	2.77e-05	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—NOS3—prostate cancer	2.78e-06	2.77e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	2.77e-06	2.76e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—GSTM1—prostate cancer	2.77e-06	2.76e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—NCOA2—prostate cancer	2.75e-06	2.75e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—TH—prostate cancer	2.74e-06	2.74e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	2.73e-06	2.72e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—GSTA2—prostate cancer	2.72e-06	2.71e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—CYP3A4—prostate cancer	2.71e-06	2.71e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—LPL—prostate cancer	2.71e-06	2.71e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	2.7e-06	2.69e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—HPGDS—prostate cancer	2.69e-06	2.68e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—SULT1A1—prostate cancer	2.69e-06	2.68e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—ABCG5—prostate cancer	2.69e-06	2.68e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—CYP2C19—prostate cancer	2.67e-06	2.67e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—CYP1B1—prostate cancer	2.67e-06	2.66e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—SLC5A5—prostate cancer	2.65e-06	2.64e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—SLC5A5—prostate cancer	2.63e-06	2.62e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—GSTA1—prostate cancer	2.63e-06	2.62e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—CYP1A1—prostate cancer	2.62e-06	2.61e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—GSTT1—prostate cancer	2.61e-06	2.6e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—ACHE—prostate cancer	2.61e-06	2.6e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—ERCC2—prostate cancer	2.6e-06	2.59e-05	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—PIK3CG—prostate cancer	2.6e-06	2.59e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—GSTO1—prostate cancer	2.6e-06	2.59e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—HSD3B2—prostate cancer	2.6e-06	2.59e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—NAT2—prostate cancer	2.6e-06	2.59e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—CYP2E1—prostate cancer	2.59e-06	2.58e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—GGT1—prostate cancer	2.58e-06	2.58e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—CYP2A6—prostate cancer	2.58e-06	2.57e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	2.57e-06	2.56e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—CYP2E1—prostate cancer	2.57e-06	2.56e-05	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—PIK3CB—prostate cancer	2.56e-06	2.56e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—NQO1—prostate cancer	2.56e-06	2.55e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—NCOA1—prostate cancer	2.55e-06	2.54e-05	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—PTGS2—prostate cancer	2.54e-06	2.53e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—NQO1—prostate cancer	2.54e-06	2.53e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—TH—prostate cancer	2.52e-06	2.52e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—AKR1C3—prostate cancer	2.51e-06	2.5e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—CYP19A1—prostate cancer	2.51e-06	2.5e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—TH—prostate cancer	2.5e-06	2.49e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—CYP3A4—prostate cancer	2.5e-06	2.49e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PRKACB—prostate cancer	2.5e-06	2.49e-05	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—PIK3CA—prostate cancer	2.49e-06	2.48e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—LRP2—prostate cancer	2.49e-06	2.48e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PLCB2—prostate cancer	2.49e-06	2.48e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CYP2C18—prostate cancer	2.49e-06	2.48e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	2.49e-06	2.48e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—CYP3A4—prostate cancer	2.48e-06	2.47e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—CYP17A1—prostate cancer	2.47e-06	2.46e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	2.46e-06	2.46e-05	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—INS—prostate cancer	2.46e-06	2.45e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—CYP1B1—prostate cancer	2.45e-06	2.45e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—MTHFR—prostate cancer	2.44e-06	2.44e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—P4HB—prostate cancer	2.44e-06	2.44e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	2.44e-06	2.43e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—CYP1B1—prostate cancer	2.43e-06	2.43e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—RXRA—prostate cancer	2.42e-06	2.41e-05	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—CREBBP—prostate cancer	2.41e-06	2.4e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—PPARA—prostate cancer	2.4e-06	2.39e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—GGT1—prostate cancer	2.38e-06	2.37e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—SLC22A1—prostate cancer	2.38e-06	2.37e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—GGT1—prostate cancer	2.36e-06	2.35e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.36e-06	2.35e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—NCOA2—prostate cancer	2.35e-06	2.35e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—NCOA1—prostate cancer	2.34e-06	2.33e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—COMT—prostate cancer	2.33e-06	2.33e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—GSTP1—prostate cancer	2.32e-06	2.31e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—NCOA1—prostate cancer	2.32e-06	2.31e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—SULT2A1—prostate cancer	2.32e-06	2.31e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—CYP19A1—prostate cancer	2.31e-06	2.3e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—CYP19A1—prostate cancer	2.29e-06	2.28e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—ITPR1—prostate cancer	2.28e-06	2.28e-05	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—PIK3CD—prostate cancer	2.28e-06	2.28e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—MED12—prostate cancer	2.28e-06	2.27e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—GNG5—prostate cancer	2.26e-06	2.25e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—CAV1—prostate cancer	2.25e-06	2.25e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.25e-06	2.24e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—SLC5A5—prostate cancer	2.25e-06	2.24e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—RXRA—prostate cancer	2.23e-06	2.22e-05	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—PTEN—prostate cancer	2.22e-06	2.21e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—RXRA—prostate cancer	2.21e-06	2.2e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—CYP2E1—prostate cancer	2.19e-06	2.19e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—NCOA3—prostate cancer	2.18e-06	2.17e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—NQO1—prostate cancer	2.17e-06	2.16e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—TYMS—prostate cancer	2.16e-06	2.15e-05	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—NOS3—prostate cancer	2.16e-06	2.15e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.15e-06	2.14e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—COMT—prostate cancer	2.15e-06	2.14e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—TH—prostate cancer	2.14e-06	2.13e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—GSTP1—prostate cancer	2.14e-06	2.13e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—GSTM1—prostate cancer	2.13e-06	2.13e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—COMT—prostate cancer	2.13e-06	2.12e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	2.12e-06	2.12e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—GSTP1—prostate cancer	2.12e-06	2.11e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—CYP3A4—prostate cancer	2.12e-06	2.11e-05	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—EP300—prostate cancer	2.11e-06	2.11e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	2.1e-06	2.1e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—ITPR1—prostate cancer	2.1e-06	2.1e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—LPL—prostate cancer	2.09e-06	2.09e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—ITPR1—prostate cancer	2.08e-06	2.08e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—CYP1B1—prostate cancer	2.08e-06	2.07e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—HPGDS—prostate cancer	2.08e-06	2.07e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CYP2C19—prostate cancer	2.06e-06	2.06e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—PIK3CG—prostate cancer	2.05e-06	2.05e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.05e-06	2.04e-05	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—AKT1—prostate cancer	2.04e-06	2.03e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—CYP1A1—prostate cancer	2.02e-06	2.02e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—GSTT1—prostate cancer	2.01e-06	2.01e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—ACHE—prostate cancer	2.01e-06	2.01e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—GGT1—prostate cancer	2.01e-06	2.01e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—ERCC2—prostate cancer	2.01e-06	2e-05	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—PIK3CB—prostate cancer	1.99e-06	1.99e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CYP2A6—prostate cancer	1.99e-06	1.99e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—TYMS—prostate cancer	1.99e-06	1.98e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—NCOA1—prostate cancer	1.98e-06	1.98e-05	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—PTGS2—prostate cancer	1.97e-06	1.97e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—TYMS—prostate cancer	1.97e-06	1.96e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—GSTM1—prostate cancer	1.96e-06	1.96e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—CYP19A1—prostate cancer	1.96e-06	1.95e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—GSTM1—prostate cancer	1.95e-06	1.94e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—INS—prostate cancer	1.94e-06	1.94e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—AKR1C3—prostate cancer	1.94e-06	1.93e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PRKACB—prostate cancer	1.93e-06	1.92e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—LPL—prostate cancer	1.93e-06	1.92e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—LPL—prostate cancer	1.91e-06	1.9e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CYP17A1—prostate cancer	1.91e-06	1.9e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—CREBBP—prostate cancer	1.9e-06	1.9e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—RXRA—prostate cancer	1.89e-06	1.88e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—MTHFR—prostate cancer	1.89e-06	1.88e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—CYP1A1—prostate cancer	1.86e-06	1.85e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—PPARA—prostate cancer	1.85e-06	1.84e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—ERCC2—prostate cancer	1.84e-06	1.84e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—CYP1A1—prostate cancer	1.84e-06	1.84e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.84e-06	1.83e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—ERCC2—prostate cancer	1.83e-06	1.82e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—COMT—prostate cancer	1.82e-06	1.81e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—NCOA2—prostate cancer	1.82e-06	1.81e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—GSTP1—prostate cancer	1.81e-06	1.8e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—PIK3CD—prostate cancer	1.81e-06	1.8e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—ITPR1—prostate cancer	1.78e-06	1.77e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.75e-06	1.75e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—CAV1—prostate cancer	1.74e-06	1.73e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—MTHFR—prostate cancer	1.73e-06	1.73e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—SLC5A5—prostate cancer	1.73e-06	1.73e-05	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—PTEN—prostate cancer	1.72e-06	1.72e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—MTHFR—prostate cancer	1.72e-06	1.71e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—NOS3—prostate cancer	1.7e-06	1.7e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—PPARA—prostate cancer	1.7e-06	1.7e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CYP2E1—prostate cancer	1.69e-06	1.69e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—PPARA—prostate cancer	1.69e-06	1.68e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—TYMS—prostate cancer	1.68e-06	1.68e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—NQO1—prostate cancer	1.67e-06	1.67e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—GSTM1—prostate cancer	1.66e-06	1.66e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.66e-06	1.66e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—TH—prostate cancer	1.65e-06	1.64e-05	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—EP300—prostate cancer	1.64e-06	1.64e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—LPL—prostate cancer	1.63e-06	1.63e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CYP1B1—prostate cancer	1.6e-06	1.6e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—CAV1—prostate cancer	1.6e-06	1.59e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—CAV1—prostate cancer	1.59e-06	1.58e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—PIK3CG—prostate cancer	1.58e-06	1.58e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—CYP1A1—prostate cancer	1.58e-06	1.57e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—PIK3CB—prostate cancer	1.57e-06	1.57e-05	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—PIK3CA—prostate cancer	1.56e-06	1.56e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—ERCC2—prostate cancer	1.56e-06	1.56e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—PTGS2—prostate cancer	1.56e-06	1.55e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—GGT1—prostate cancer	1.55e-06	1.55e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—NCOA1—prostate cancer	1.53e-06	1.53e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.52e-06	1.51e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.51e-06	1.5e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—INS—prostate cancer	1.5e-06	1.5e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—MTHFR—prostate cancer	1.47e-06	1.46e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—CREBBP—prostate cancer	1.47e-06	1.46e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—PIK3CG—prostate cancer	1.46e-06	1.45e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—RXRA—prostate cancer	1.46e-06	1.45e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—PIK3CG—prostate cancer	1.44e-06	1.44e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PPARA—prostate cancer	1.44e-06	1.44e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—COMT—prostate cancer	1.4e-06	1.4e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—GSTP1—prostate cancer	1.4e-06	1.39e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—PIK3CD—prostate cancer	1.39e-06	1.39e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—INS—prostate cancer	1.38e-06	1.38e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—ITPR1—prostate cancer	1.37e-06	1.37e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—INS—prostate cancer	1.37e-06	1.36e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—PTEN—prostate cancer	1.36e-06	1.36e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—CAV1—prostate cancer	1.36e-06	1.35e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—CREBBP—prostate cancer	1.35e-06	1.35e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—CREBBP—prostate cancer	1.34e-06	1.34e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—NOS3—prostate cancer	1.32e-06	1.31e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—TYMS—prostate cancer	1.3e-06	1.29e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—EP300—prostate cancer	1.3e-06	1.29e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.29e-06	1.29e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—GSTM1—prostate cancer	1.28e-06	1.28e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—PIK3CD—prostate cancer	1.28e-06	1.28e-05	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—AKT1—prostate cancer	1.28e-06	1.27e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—PIK3CD—prostate cancer	1.27e-06	1.27e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—LPL—prostate cancer	1.26e-06	1.26e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PIK3CG—prostate cancer	1.23e-06	1.23e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.22e-06	1.21e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—PIK3CB—prostate cancer	1.21e-06	1.21e-05	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—PIK3CA—prostate cancer	1.21e-06	1.21e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—NOS3—prostate cancer	1.21e-06	1.21e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—ERCC2—prostate cancer	1.21e-06	1.2e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—PTGS2—prostate cancer	1.2e-06	1.2e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—NOS3—prostate cancer	1.2e-06	1.2e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—INS—prostate cancer	1.17e-06	1.17e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—CREBBP—prostate cancer	1.14e-06	1.14e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—MTHFR—prostate cancer	1.13e-06	1.13e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—PIK3CB—prostate cancer	1.12e-06	1.11e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PPARA—prostate cancer	1.11e-06	1.11e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—PIK3CB—prostate cancer	1.11e-06	1.1e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—PTGS2—prostate cancer	1.11e-06	1.1e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—PTGS2—prostate cancer	1.1e-06	1.09e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PIK3CD—prostate cancer	1.09e-06	1.08e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—PTEN—prostate cancer	1.05e-06	1.05e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CAV1—prostate cancer	1.05e-06	1.04e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—NOS3—prostate cancer	1.02e-06	1.02e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—EP300—prostate cancer	1e-06	9.97e-06	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—AKT1—prostate cancer	9.91e-07	9.89e-06	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—PTEN—prostate cancer	9.65e-07	9.62e-06	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—PIK3CA—prostate cancer	9.59e-07	9.56e-06	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—PTEN—prostate cancer	9.56e-07	9.54e-06	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PIK3CG—prostate cancer	9.53e-07	9.5e-06	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PIK3CB—prostate cancer	9.46e-07	9.43e-06	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PTGS2—prostate cancer	9.37e-07	9.34e-06	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—EP300—prostate cancer	9.2e-07	9.17e-06	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—EP300—prostate cancer	9.12e-07	9.09e-06	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—INS—prostate cancer	9.02e-07	8.99e-06	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CREBBP—prostate cancer	8.83e-07	8.81e-06	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PIK3CD—prostate cancer	8.37e-07	8.35e-06	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PTEN—prostate cancer	8.17e-07	8.15e-06	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—NOS3—prostate cancer	7.91e-07	7.88e-06	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—AKT1—prostate cancer	7.84e-07	7.81e-06	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—EP300—prostate cancer	7.79e-07	7.77e-06	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—PIK3CA—prostate cancer	7.4e-07	7.38e-06	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PIK3CB—prostate cancer	7.3e-07	7.28e-06	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PTGS2—prostate cancer	7.23e-07	7.21e-06	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—PIK3CA—prostate cancer	6.81e-07	6.79e-06	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—PIK3CA—prostate cancer	6.75e-07	6.73e-06	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PTEN—prostate cancer	6.31e-07	6.29e-06	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—AKT1—prostate cancer	6.05e-07	6.03e-06	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—EP300—prostate cancer	6.02e-07	6e-06	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PIK3CA—prostate cancer	5.77e-07	5.75e-06	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—AKT1—prostate cancer	5.56e-07	5.54e-06	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—AKT1—prostate cancer	5.51e-07	5.5e-06	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—AKT1—prostate cancer	4.71e-07	4.7e-06	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PIK3CA—prostate cancer	4.45e-07	4.44e-06	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—AKT1—prostate cancer	3.64e-07	3.62e-06	CbGpPWpGaD
